NexoBrid - supply shortage
Shortage resolved
concentrate of proteolytic enzymes enriched in bromelain
ShortageHuman
Estonian is available via eTranslation, the European Commission's machine translation service.
Translate to Estonian | Important information about machine translation
Shortage information
A problem with a quality control test used during the manufacture of NexoBrid 5 g led to supply shortages from October 2025. The issue has been resolved, and NexoBrid is now being distributed again. The shortage has ended, and the information and recommendations provided during the shortage no longer apply.
Key facts
- Medicines affected
- NexoBrid
- Supply shortage status
- Shortage resolved
- International non-proprietary name (INN) or common name
- concentrate of proteolytic enzymes enriched in bromelain
- Therapeutic area (MESH)
- Debridement
- Availability of alternatives
- No
Key dates
- First published
- Last updated